Raises 2025 revenue view by $40M to $4.095B-$4.21B, consensus $4.11B. Maintains a consistent outlook for organic revenue growth projected at 6%-9%.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IDXX:
- Is IDXX a Buy, Before Earnings?
- Idexx Laboratories: Strong Earnings Growth and Innovation Drive Buy Rating
- Idexx Laboratories price target lowered to $475 from $535 at BofA
- Idexx Laboratories price target lowered to $548 from $559 at Morgan Stanley
- Idexx Laboratories price target lowered to $420 from $450 at Stifel